Key facts
- Talkiatry’s last known valuation is $1.4B (Feb 2026).
- It has raised $429.0M; the latest was Later Stage VC ($210.0M) in Feb 2026.
- Notable investors include Y Combinator, Andreessen Horowitz, General Catalyst, Gaingels, Left Lane Capital — 15 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Talkiatry
- ·The full record, as it builds
Funding rounds
No funding rounds for Talkiatry are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Talkiatry
Provider of mental health care services intended to expand access to treatment opportunities. The company utilizes an interactive process with evidence-based scales to offer a preliminary diagnosis and severity on the spot, enabling people to easily seek in-network and quality healthcare.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2019
- Employees
- 601
- Website
- talkiatry.com/
- Ownership
- Privately Held (backing)
Talkiatry doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Talkiatry shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Talkiatry in its N-PORT filings yet. We sweep new filings monthly.